共 50 条
- [1] CLINICAL USE OF DDMP (2,4-DIAMINO-5-(3'5' DICHLOROPHENYL)-6-METHYL PYRIMIDINE) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 15 - 15
- [3] 2,4-Diamino-5-(2′-arylpropargyl)pyrimidine derivatives as new nonclassical antifolates for human dihydrofolate reductase inhibition JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2011, 29 (05): : 608 - 613
- [4] PHARMACOKINETICS OF 2,4-DIAMINO-5-ADAMANTYL-6-METHYL PYRIMIDINE (DAMP) IN DOGS PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 225 - 225
- [6] METABOLISM AND EXCRETION OF 2,4-DIAMINO-5-(1-ADAMANTYL)-6-METHYLPYRIMIDINE(DAMP), A NEW ANTIFOLATE PHARMACOLOGIST, 1979, 21 (03): : 174 - 174
- [7] UPTAKE OF 2,4-DIAMINO-5-(3',4'-DI-CHLOROPHENYL)-6-METHYL PYRIMIDINE (DDMP) AND AMETHOPTERIN (AM) BY TUMORS AND NORMAL TISSUES PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1968, 9 (MAR): : 49 - &
- [10] COMPARISON OF METABOLISM AND INVITRO STABILITY OF 2,4-DIAMINO-6-METHYL-5-ADAMANTYL-(DAMP) AND 5-DICHLOROPHENYL-PYRIMIDINE (DDMP) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 73 - 73